Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled interferon beta-1a for prevention of severe asthma exacerbations after upper respiratory tract infection
2014-005084-32Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2015
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Interferon beta-1a with Placebo (2 arms). Primary endpoint: Number of severe exacerbations. Started Apr 2015; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
asthma
Beyond the preview
Go deeper on 2014-005084-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005084-32.